YG1699
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for YG1699, covering 2024-10-18 to 2024-10-18. Get the full timeline:
Most recent: Clinical Trial Update: PK and PD of YG1699 in CKD Patients With Diabetes [Phase 1]